首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   27402篇
  免费   3156篇
  国内免费   629篇
耳鼻咽喉   120篇
儿科学   492篇
妇产科学   1255篇
基础医学   1583篇
口腔科学   272篇
临床医学   8061篇
内科学   3712篇
皮肤病学   317篇
神经病学   1229篇
特种医学   1761篇
外国民族医学   9篇
外科学   3098篇
综合类   4395篇
现状与发展   3篇
预防医学   1332篇
眼科学   457篇
药学   1396篇
  54篇
中国医学   323篇
肿瘤学   1318篇
  2024年   76篇
  2023年   564篇
  2022年   945篇
  2021年   1323篇
  2020年   1604篇
  2019年   1349篇
  2018年   1307篇
  2017年   1348篇
  2016年   1337篇
  2015年   1323篇
  2014年   2299篇
  2013年   2094篇
  2012年   1545篇
  2011年   1693篇
  2010年   1305篇
  2009年   1228篇
  2008年   1286篇
  2007年   1267篇
  2006年   1056篇
  2005年   848篇
  2004年   714篇
  2003年   679篇
  2002年   538篇
  2001年   450篇
  2000年   352篇
  1999年   350篇
  1998年   293篇
  1997年   285篇
  1996年   241篇
  1995年   209篇
  1994年   179篇
  1993年   156篇
  1992年   127篇
  1991年   121篇
  1990年   97篇
  1989年   75篇
  1988年   73篇
  1987年   55篇
  1986年   64篇
  1985年   94篇
  1984年   68篇
  1983年   24篇
  1982年   48篇
  1981年   30篇
  1980年   23篇
  1979年   22篇
  1978年   9篇
  1977年   5篇
  1976年   3篇
  1973年   2篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
目的:探讨嗅鞘细胞(olfactory ensheathing cells,OEC)移植在大鼠损伤脊髓后是否有独特的迁移和轴突生长导向特性。方法:将表达绿色荧光蛋白基因的OEC注入到C4脊髓损伤大鼠距离损伤部位头端1mm及尾端1mm背柱白质处,注射后1、3、12、24h及3、7、28d灌注固定取材,冰冻切片和免疫组化分析。用骨髓基质细胞和成纤维细胞移植到同样的损伤部位做为对照进行同样的分析。另将OEC注射到距离损伤部位头尾侧1mm处脊髓灰质内、小剂量注射在白质内、在损伤前3d或损伤后9d注射、注射到未损伤脊髓白质中,观察细胞迁移情况。结果:OEC在细胞注射后1h内即形成由注射压力造成的从注射部位向损伤处的被动性延伸带,并且不断地从注射部位向损伤处延伸扩散,在形态学方面好象起到"桥接"损伤处的作用。对照组骨髓基质细胞和成纤维细胞注射后也迅速形成细胞"桥接"带,并扩散至损伤空腔。将OEC注射到脊髓灰质内或小剂量注射或注射到未损伤的脊髓白质内、在脊髓损伤3d前或9d后注射细胞均没有见到细胞带延伸进入损伤部位。OEC在注射部位、细胞带以及损伤部位有增殖现象。28d后,共焦免疫酶标法证实细胞带取代了脊髓原有星形胶质细胞,但是下行或上行长束轴突没有优先延伸至该细胞带,也没能起到维持皮层脊髓轴突的桥接作用。结论:OEC在植入大鼠损伤脊髓后没有独特的迁移特性,与骨髓基质细胞或成纤维细胞相比没有明显促进轴突生长的作用,也没有支持皮层脊髓轴突在脊髓损伤处形成桥接的作用。  相似文献   
92.
Although observational studies suggest that hyperhomocysteinemia may be a risk factor for coronary allograft vasculopathy (CAV), prospective data on homocysteine-lowering interventions and CAV development are lacking. We, therefore, randomized 44 de novo heart transplant (HT) recipients to 15 mg/day of 5-methyl-tetrahydrofolate (n=22), or standard therapy (control group, n=22) to investigate the effect of homocysteine lowering on the change in coronary intimal hyperplasia during the first 12 months after transplant, as detected by intra-vascular ultrasound (IVUS). Although 12 months after HT, homocysteinemia was lower in folate-treated patients (p<0.001), coronary intimal area increased similarly in the two groups (p>0.4). Conversely, hypercholesterolemia and cytomegalovirus infection were both associated with increased intimal hyperplasia (p<0.04), independently from folate intake. Sub-group analysis revealed that folate therapy reduced intimal hyperplasia in patients with hyperhomocysteinemia before randomization (n=19; p=0.02), but increased intimal hyperplasia in patients with normal homocysteine plasma concentrations (p=0.02). This bimodal effect of folate therapy persisted significantly after adjusting for cytomegalovirus infection and hypercholesterolemia. Despite effective in prevent hyperhomocysteinemia after heart transplantation, folate therapy does not seem to affect early CAV onset. However, sub-group analysis suggests that folate therapy may delay CAV development only in patients with baseline hyperhomocysteinemia, while may favor CAV progression in recipients with normal baseline homocysteinemia.  相似文献   
93.
毕四锐 《心脏杂志》2006,18(2):228-230
目的评价螺内酯联合依那普利治疗老年人扩张型心肌病(DCM)心力衰竭的有效性和安全性。方法以148例老年DCM心力衰竭患者作研究对象,按随机化原则分为观察组(74例)和对照组(74例)。对照组为依那普利,加上基础用药(地高辛、双氢克尿噻);观察组为对照组用药加上螺内酯。治疗6周后复查两组的动态心电图、超声心动图。结果治疗后两组的左室射血分数(LVEF)均有增加,左室收缩末期容积(LVESV)和左室舒张末期容积(LVEDV)均有减少,24 h室性早搏(VA)数也均有减少;观察组与对照组比较,LVEF显著增加。两组均未发现高血钾及肝肾功能损害。结论在老年DCM心力衰竭常规用药的基础上,常规加用螺内酯联合依那普利的治疗有效、安全,可显著改善左室重构和防治猝死。  相似文献   
94.
Objective. The objective of our paper is to show that the spatio-temporal image correlation (STIC) and tomographic ultrasound imaging (TUI) is very convenient and helpful for the fetal screening of complex congenital heart defects (CHD).

Methods. Ultrasound examinations were performed using a Voluson 730 EXPERT or PRO system (GE Medical system, Kretztechnik, Zipf, Austria), and the transabdominal probe (RAB 4-8 MHz or 1-5 MHz) was used to acquire the STIC volumes. Various complex CHD including heterotaxia, ventricular septal defect (VSD), atrio-ventricular septal defect (AVSD), tetralogy of fallot (TOF), transposition of great artery (TGA), hypoplastic left heart syndrome (HLHS) were examined between 20 weeks and 35 weeks. After routine cardiac screening and examination by two-dimensional ultrasound, three- and four-dimensional ultrasound were performed by gray-scaled and color flow mapping. After the examination detailed analysis of CHD were performed by STIC and TUI.

Results. In the case of heterotaxia, STIC and TUI was useful for the detection of stomach and cardiac apex in the different slices. In the case of VSD and AVSD, they were useful for the exact determination of septal defect location. In the cases of TOF, TGA and HLHS, they were helpful for observation of outflow tract and exact diagnosis.

Conclusion. In the screening of complex CHD including heterotaxia, VSD, AVSD, TOF, TGA and HLHS, STIC is very useful and powerful tool.  相似文献   
95.
目的探讨高频超声引导定位穿刺前臂浅静脉的应用价值。方法对40例常规浅静脉穿刺失败,采用高频探头在同一体表区域寻找并标记浅静脉走行及深度,确认进针方向后再次静脉穿刺,必要时采用实时引导。结果11例经高频超声标记、29例经高频超声实时引导静脉穿刺均一次成功。结论高频超声引导下静脉穿刺的成功率高,无并发症,是一种简便有效的方法,值得在临床推广应用。  相似文献   
96.
彩超引导介入治疗腘窝囊肿23例   总被引:3,自引:0,他引:3  
目的探讨彩超引导下腘窝囊肿介入治疗的价值。方法在彩超引导下穿刺囊肿并抽尽囊液,生理盐水反复冲洗囊腔后注入无水乙醇,5min后抽出,反复2~3次。结果23例中22例穿刺一次治愈,1例穿刺2次治愈。23例随访6个月,无复发。结论彩超引导下介入治疗腘窝囊肿操作简便,创伤轻微,安全可靠,效果显著,可重复操作。  相似文献   
97.
彩超、增强磁共振动脉造影对颅外颈动脉狭窄的术前评估   总被引:4,自引:0,他引:4  
目的 评价彩超、增强磁共振动脉造影(CEMRA)对颅外颈动脉狭窄的术前评估价值。方法 回顾分析了93例因颅外颈动脉狭窄而接受介入治疗患者的术前彩超、CEMRA检查结果。结果 超声检查可判断狭窄性质和狭窄程度,CEMRA能显示颈动脉全程,显示多发狭窄。但两者对狭窄程度都有过高评估的倾向,对斑块溃疡难以显示。结论 就目前彩超和磁共振机器的性能,尚无法替代DSA检查。必须有机地结合彩超、CEMRA和DSA检查,以多侧面、全方位地了解狭窄的颈动脉,制定合理的治疗方案。  相似文献   
98.
BACKGROUND AND PURPOSE: The Doppler waveform patterns of loss of diastolic flow, appearance of retrograde diastolic flow, or no detectable flow in the cerebral arteries suggest significantly abnormal cerebral blood flow (CBF). A retrospective study was performed to show that significantly abnormal CBF alone, without clinical criteria, is not necessarily specific to brain death in the young pediatric population. PATIENTS AND METHODS: Forty-seven pediatric patients, from newborn to 4 years of age, were found to have significantly abnormal CBF, including 7 patients with loss of diastolic flow, 28 with retrograde diastolic flow, and 23 with no detectable cerebral flow on serial Doppler sonographic examinations. Their clinical data and sonographic results were collected and analyzed. RESULTS: Forty-two patients died, a few of whom had only transient improvement of cerebral flow. All of the patients with no detectable cerebral flow expired. Five patients survived with or without sequelae. Their underlying conditions that caused increased intracranial pressure were treated by medical and/or surgical intervention, and diastolic reversal of CBF corrected within 1 day in all 5. CONCLUSIONS: Although no detectable flow is a lethal sign, pediatric patients with loss or reversal of diastolic flow may survive with prompt and effective treatment. Using Doppler ultrasound to diagnose cerebral circulatory arrest should be done with caution in pediatric patients.  相似文献   
99.
脾脏肿块的超声诊断   总被引:1,自引:0,他引:1  
目的 :探讨脾脏肿块的超声表现及鉴别要点。材料和方法 :回顾性分析 76例脾脏肿块患者的超声检查资料 ,分析脾脏肿块的大小、数目、边界、内部回声等多种超声表现。结果 :76例脾脏肿块中有 3例错构瘤 ,10例血管瘤 ,16例淋巴瘤 ,2例淋巴管瘤 ,4例血管肉瘤 ,11例脾转移瘤 ,16例脾囊肿 ,4例脾梗死 ,3例脾血肿 ,5例脾脓肿 ,2例付脾 ,其超声表现各具特征。结论 :超声检查可早期发现并区别脾脏肿块的囊、实性 ,借助彩色血流显像可进一步鉴别良、恶性病灶。  相似文献   
100.
Hepatic venous outflow tract obstruction, Budd-Chiari syndrome (BCS), leads to portal hypertension and to the development of collaterals that bypass the obstruction. Described here is a BCS patient with an unusually large transdiaphragmatic collateral between the left hepatic and left innominate veins, which decompressed the oesophageal varices. This has not been reported earlier in the literature.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号